Array Bridge is testing promising drug candidates that can effectively bind and even degrade target proteins, but not via ...

He added: “We have seen no significant gene misregulation attributable to ... abnormalities and mutations in the RUNX1 and PTPN11 genes typically associated with the development of the disease.